MATTHEW R. MCBRADY, PH.D - Corporate Board Profile

AXON ENTERPRISE, INC.

Filing Date	Source Excerpt
2020-04-15	Matthew R. McBrady, Ph.D Director since 2016 Class B Age: 49 Board Committees: Audit Committee, Compensation Committee, Merger and Acquisition Committee (Chair) ... The following table summarizes the compensation paid to non-employee directors for the fiscal year ended December 31, 2019. ... Matthew McBrady Fees Earned or Paid in Cash: $62,000, Stock Awards: $160,005, Total: $222,005.
2022-04-08	Matthew R. McBrady, Ph.D Director since 2016 Class B Age: 51 Board Committees: Enterprise Risk and Information Security Committee, Merger and Acquisition and Capital Structures Committee (Chair) ...In 2021, the following table summarizes the compensation paid to non-employee directors for the fiscal year ended December 31, 2021. Matthew R. McBrady: Fees Earned or Paid in Cash $72,000, Stock Awards $200,014, Total $272,014.
2023-04-21	Matthew R. McBrady, Ph.D Director since 2016 Age: 52 Board Committees: Enterprise Risk and Information Security Committee and Merger and Acquisition and Capital Structure Committee (Chair) ... Dr. McBrady is a professor and investment professional. The following table summarizes the compensation paid to non-employee directors for the fiscal year ended December 31, 2022. Matthew R. McBrady: Total $260,467.
2024-03-29	Matthew R. McBrady, Ph.D Director since 2016 Age: 53 Board Committees: Enterprise Risk and Compliance Committee, Mergers and Acquisitions and Capital Structure Committee (Chair) and Scientific and Medical Committee From August 1998 through January 2000, Dr. McBrady served as an international economist with President Clinton’s Council of Economic Advisers and the U.S. Treasury Department. From 2002 to 2006, Dr. McBrady served as a Professor of Finance at the Wharton School of Business at the University of Pennsylvania (from September 2002 through May 2003) and at the Darden Graduate School of Business Administration at the University of Virginia (from May 2003 through December 2006). After leaving academia, Dr. McBrady joined the North American Private Equity group at Bain Capital, LLC where he worked as an investment professional from January 2007 through January 2009 prior to joining Silver Creek Capital Management, LLC as Managing Director and Head of Investment Strategy and Risk Management. In January 2014, Dr. McBrady joined BlackRock, Inc., where he served as Managing Director and Chief Investment Officer of Multi-Strategy Hedge Funds from January 2014 through September 2016. Dr. McBrady served as the Managing Director of Investments at the Cystic Fibrosis Foundation from September 2017 to January 2019 and a Senior Advisor and co-Chief Investment Officer of Callaway Capital from January 2017 to December 2019. Dr. McBrady returned to the Darden Graduate School of Business Administration as a Professor of Finance Practice in August 2022, where he teaches classes in Corporate Financial Strategy and Impact and ESG Investing. In addition to his work in the private sector and academia, Dr. McBrady currently serves as an advisor to a number of impact investing funds and as the Chairman of the Investment Committee for Global Partnerships, a non-profit impact investor that has deployed nearly $500 million in concessionary loans to improve the lives of people living at the bottom of the pyramid in Central and South America and Africa. Dr. McBrady holds a B.A. in Economics from Harvard University, a M.Sc. in International Economics from Oxford University (U.K.) and a Ph.D. in Business Economics from Harvard University.